RxDoctor Payments DataLook up a doctor →

Phillip Triplett, DO

Internal Medicine · Charleston, WVNPI 1083645758

Payments from drug & device makers

$16,574in general payments, 2019–2025

Across 872 payments — averaging $19.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$3K
  • AbbVie$3K
  • AstraZeneca$1K
  • Johnson & Johnson$950
  • Lilly USA, LLC$876
  • Novartis$757
  • plus $7K from 49 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)163$3,221
AbbVie(2 entities)105$2,544
AstraZeneca(2 entities)70$1,432
Johnson & Johnson(2 entities)47$950
Lilly USA, LLC60$876
Novartis46$757
GSK39$756
Novo Nordisk43$652
UCB, Inc.31$602
Boehringer Ingelheim31$513
Pfizer26$465
Amarin Pharma, Inc.41$438
Aurinia Pharma U.S., Inc.15$327
ANI Pharmaceuticals, Inc.6$297
Sanofi-aventis U.S. LLC18$288
Bristol Myers Squibb9$212
Dexcom, Inc.7$172
Organon8$156
Bayer9$155
Exact Sciences8$146
Astellas Pharma US Inc7$134
Mallinckrodt Hospital Products Inc.5$115
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC7$98
Biohaven Pharmaceutical Holding Company Ltd.5$97
Shield Therapeutics Inc4$93
Abbott5$92
Amneal Pharmaceuticals LLC5$89
Regeneron Healthcare Solutions, Inc.5$84
Radius Health, Inc.3$67
Tonix Medicines, Inc.2$60
Phathom Pharmaceuticals, Inc.3$52
Mallinckrodt Enterprises LLC2$51
Genentech USA, Inc.3$47
Bioventus LLC3$46
Merck3$46
Daiichi Sankyo Inc.3$45
Invivyd Inc2$36
Takeda Pharmaceuticals U.S.A., Inc.3$36
Alnylam Pharmaceuticals Inc.1$28
Fresenius Kabi USA, LLC2$27
Redhill Biopharma Inc.2$26
Smith+Nephew1$26
Arbor Pharmaceuticals, Inc.2$25
Octapharma USA, Inc.1$21
Sandoz1$21
Ferring Pharmaceuticals Inc.1$18
Collegium Pharmaceutical, Inc.1$17
Kiniksa Pharmaceuticals International, PLC1$16
E.r. Squibb & Sons, L.L.C.1$16
Esperion Therapeutics, Inc.1$16
Shionogi Inc1$16
Biohaven Pharmaceuticals, Inc.1$16
Seqirus USA Inc1$15
Hospira, Inc.1$14
Teva Pharmaceuticals USA, Inc.1$12

How this compares

$16,574 in reported general payments places this provider in the 95th percentile of 573 internal medicine providers in West Virginia.

See all internal medicine providers in West Virginia →

Medicare billing

Part B allowed, 2024
$170,736
Medicare patients
229
Services billed
4,662

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Charleston

See the full list for West Virginia →

Where these figures come from

Is this you, or does something look wrong? →